NCT00791804 - Phase II Study of Inhaled AeroLEF for Analgesia After ACL Knee Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

December 31, 2004

Conditions

PainPost Operative Pain

Interventions

DRUG

AeroLEF

"Inhaled AeroLEF (Liposome-Encapsulated Fentanyl 500 mcg/mL)~* for nebulized administration as required by the patient.~* Up to a 6 mL volume (2 x 3 mL doses) containing 500 mcg/ml fentanyl."

Trial Locations (2)

B3H 1V8

Queen Elizabeth II Health Sciences Centre, Capital Health, Halifax

M8V 2Z6

University Health Network, Toronto Western Hospital, Toronto